FDA Wants More Trials for Alimera's Eye Drug

"U.S. health regulators declined to approve Alimera Sciences Inc's experimental drug to treat retinal swelling for the second time citing safety issues, and asked the biopharmaceutical company to conduct two more trials," according to a Reuters post. Read more.